Written by: JR Robinson

The Cystic Fibrosis Foundation of Memphis is at the forefront of the fight against cystic fibrosis (CF), playing a crucial role in funding groundbreaking research and accelerating the development of life-changing therapies.

Advancing the Science of CF

Through its unwavering commitment and strategic investments, the Memphis chapter has been instrumental in propelling the field of CF research forward. In 2022 alone, the Cystic Fibrosis Foundation allocated a staggering $265 million towards research and care initiatives nationwide.

This funding has enabled scientists and clinicians to make remarkable strides in understanding the underlying mechanisms of CF and exploring innovative treatment approaches. From investigating rare CFTR mutations to developing personalized therapies, the research supported by the Memphis chapter is transforming the lives of those affected by this devastating disease.

Tackling Rare Mutations

One area of focus for the Memphis chapter has been the study of rare CFTR mutations, which are often seen in minority populations. By supporting research on mutations like c.3623G>A, the chapter is helping to expand the scientific community's knowledge and pave the way for more targeted, effective interventions.

"The work being done by the Memphis chapter is truly groundbreaking," said Dr. Gabor J. Tigyi, a renowned CF researcher. "By shedding light on these lesser-known mutations, they are not only improving our understanding of the disease but also ensuring that no one is left behind in the pursuit of a cure."

Empowering Personalized Care

The Memphis chapter's commitment to research also extends to the development of personalized treatment approaches. Through its collaboration with the University of Tennessee Health Science Center and other leading institutions, the chapter is driving the implementation of mutation-specific therapies that address the root cause of CF.

"The ability to tailor treatments to an individual's genetic profile is a game-changer in CF care," explained Dr. Amanda Preston, a scientific editor at the Children's Foundation Research Institute. "The Memphis chapter's support for this work is truly making a difference in the lives of patients, giving them hope for a brighter future."

A Community-Driven Effort

The success of the Memphis chapter's research initiatives is a testament to the power of community engagement. Through events like the annual Great Strides walk, the chapter has been able to rally the local community and secure the necessary funding to fuel its ambitious research agenda.

"The support we receive from the Memphis community is truly humbling," said Angela Bledsoe, the Director of Development for the Memphis chapter. "It's a testament to the resilience and determination of those affected by CF, and it's what drives us to continue pushing the boundaries of what's possible."

As the Cystic Fibrosis Foundation of Memphis continues to lead the charge in CF research, the future looks brighter than ever for those living with this complex and challenging disease. With the community's unwavering support, the chapter is poised to make even greater strides in the years to come.